BGOG-ov-39

A Phase III, multicenter, randomized, Study of Atezolizumab Versus Placebo in combination with Paclitaxel, carboplatin, and Bevacizumab for patients with Newly diagnosed stage III/IV ovarian, fallopian tube, or primary peritoneal cancer